This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Allergic Rhinoconjunctivitis
and you are
between 18 and 64
years old
This is an advanced phase trial assessing
the effectiveness of the new treatment before being released on the market.
Show me locations

The purpose

The purpose of the trial is to evaluate the efficacy of two dosing schedules of Avanz SQ+ (Standardised Quality) Phleum pratense compared to placebo in subjects with grass pollen induced allergic rhinoconjunctivitis with or without asthma.

Provided treatments

  • Drug: Avanz Phleum pratense
  • Drug: Placebo

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01438827. The sponsor of the trial is ALK-Abelló A/S and it is looking for 450 volunteers for the current phase.
Official trial title:
Avanz Phleum Pratense Maintenance Dose